Elevated VEGF levels contribute to the pathogenesis of osteoarthritis

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Yuan, Quan ^a   Sun, Li ^a   Li, Jian Jun ^a   An, Chun Hou ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Osteoarthritis; Pathogenesis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; ASIAN; CAUCASIAN; CHINESE BIOMEDICAL DATABASE; CINAHL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL (TOPIC); EMBASE; ETHNICITY; HUMAN; LANGUAGE; MEDLINE; META ANALYSIS; MOLECULAR PATHOLOGY; OSTEOARTHRITIS; PROTEIN EXPRESSION; WEB OF SCIENCE; CASE CONTROL STUDY; METABOLISM;

CASE-CONTROL STUDIES; HUMANS; OSTEOARTHRITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84926647455     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-437     Document Type: Article

References (39)

1. Zhang ZM, Li ZC, Jiang LS, Jiang SD, Dai LY: Micro-CT and mechanical evaluation of subchondral trabecular bone structure between postmenopausal women with osteoarthritis and osteoporosis. Osteoporos Int 2010,21(8):1383-1390. 10.1007/s00198-009-1071-2
2. Jin WJ, Jiang SD, Jiang LS, Dai LY: Differential responsiveness to 17beta-estradiol of mesenchymal stem cells from postmenopausal women between osteoporosis and osteoarthritis. Osteoporos Int 2012,23(10):2469-2478. 10.1007/s00198-011-1859-8
3. Fay J, Varoga D, Wruck CJ, Kurz B, Goldring MB, Pufe T: Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res Ther 2006,8(6):R189. 10.1186/ar2102
4. Young DA, Bui C, Barter MJ: Understanding CpG methylation in the context of osteoarthritis. Epigenomics 2012,4(6):593-595. 10.2217/epi.12.63
5. Fransen M, Bridgett L, March L, Hoy D, Penserga E, Brooks P: The epidemiology of osteoarthritis in Asia. Int J Rheum Dis 2011,14(2):113-121. 10.1111/j.1756-185X.2011.01608.x
6. Prieto-Alhambra D, Nogues X, Javaid MK, Wyman A, Arden NK, Azagra R, Cooper C, Adachi JD, Boonen S, Chapurlat RD, Compston JE, Gehlbach SH, Greenspan SL, Hooven FH, Netelenbos JC, Pfeilschifter J, Rossini M, Sambrook PN, Silverman S, Siris ES, Watts NB, Diez-Perez A: An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Ann Rheum Dis 2013,72(6):911-917. 10.1136/annrheumdis-2012-201451
7. Neogi T, Zhang Y: Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2013,39(1):1-19. 10.1016/j.rdc.2012.10.004
8. Loeser RF, Goldring SR, Scanzello CR, Goldring MB: Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012,64(6):1697-1707. 10.1002/art.34453
9. Corrado A, Neve A, Cantatore FP: Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. Clin Exp Med 2013,13(1):81-84. 10.1007/s10238-011-0170-5
10. Giner M, Montoya MJ, Vazquez MA, Miranda C, Perez-Cano R: Differences in osteogenic and apoptotic genes between osteoporotic and osteoarthritic patients. BMC Musculoskelet Disord 2013, 14:41. 10.1186/1471-2474-14-41
11. Neve A, Cantatore FP, Corrado A, Gaudio A, Ruggieri S, Ribatti D: In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment. Regul Pept 2013, 184:81-84.
12. Tahara A, Tsukada J, Tomura Y, Yatsu T, Shibasaki M: Vasopressin induces human mesangial cell growth via induction of vascular endothelial growth factor secretion. Neuropeptides 2011,45(2):105-111. 10.1016/j.npep.2010.12.001
13. Poh CK, Shi Z, Lim TY, Neoh KG, Wang W: The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 2010,31(7):1578-1585. 10.1016/j.biomaterials.2009.11.042
14. Cui Q, Dighe AS, Irvine JN Jr: Combined angiogenic and osteogenic factor delivery for bone regenerative engineering. Curr Pharm Des 2013,19(19):3374-3383. 10.2174/1381612811319190004
15. Bates DO: Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 2010,87(2):262-271. 10.1093/cvr/cvq105
16. Wise LM, Inder MK, Real NC, Stuart GS, Fleming SB, Mercer AA: The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration. Cell Microbiol 2012,14(9):1376-1390. 10.1111/j.1462-5822.2012.01802.x
17. Cebi H, Aksahin E, Yuksel HY, Celebi L, Aktekin CN, Hapa O, Muratli HH, Bicimoglu A: Plasma vascular endothelial growth factor levels are similar in subjects with and without osteoporosis. Eklem Hastalik Cerrahisi 2010,21(2):91-97.
18. Saetan N, Honsawek S, Tanavalee A, Yuktanandana P, Meknavin S, Ngarmukos S, Tanpowpong T, Parkpian V: Relationship of plasma and synovial fluid vascular endothelial growth factor with radiographic severity in primary knee osteoarthritis. Int Orthop 2013,38(5):1099-104.
19. Ballara S, Taylor PC, Reusch P, Marme D, Feldmann M, Maini RN, Paleolog EM: Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 2001,44(9):2055-2064. 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2
20. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010,25(9):603-605. 10.1007/s10654-010-9491-z
21. Zintzaras E, Ioannidis JP: HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005,21(18):3672-3673. 10.1093/bioinformatics/bti536
22. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L: Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006,295(6):676-680. 10.1001/jama.295.6.676
23. Chen NJ: Expression of vascular endothelial growth factor and transforming growth factor-beta1 in synovial membrance of osteoarthritis and their relationships. J Clin Rehabilitative Tissue Engineering Re 2009,13(2):288-291.
24. Duan X, Li Q, Li LJ, Liu CL, Li ZH, Li DJ, Zhang F: Expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in the synovium of patients with osteoarthritis. J Southern Med Univ 2011,31(1):117-120.
25. Su W, Xie W, Guan M: [Detection of vascular endothelial growth factor in patients with osteoarthritis]. Labor Med 2008,23(1):42-46.
26. Zhu BY, Wang QY, Wu B, Wang WC, Tian J: The significance of IL-6 and VEGF expression in patients with knee osteparthritis. Chin J Gerontol 2012, 2:273-275.
27. Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, Matsumoto H, Toyama Y, Okada Y: Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003,162(1):171-181. 10.1016/S0002-9440(10)63808-4
28. Huh JE, Seo DM, Baek YH, Choi DY, Park DS, Lee JD: Biphasic positive effect of formononetin on metabolic activity of human normal and osteoarthritic subchondral osteoblasts. Int Immunopharmacol 2010,10(4):500-507. 10.1016/j.intimp.2010.01.012
29. Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY: Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001,19(3):321-324.
30. Pfander D, Kortje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, Cramer T, Swoboda B: Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 2001,60(11):1070-1073. 10.1136/ard.60.11.1070
31. Nishimura A, Hasegawa M, Kato K, Yamada T, Uchida A, Sudo A: Risk factors for the incidence and progression of radiographic osteoarthritis of the knee among Japanese. Int Orthop 2011,35(6):839-843. 10.1007/s00264-010-1073-x
32. Hashimoto S, Creighton-Achermann L, Takahashi K, Amiel D, Coutts RD, Lotz M: Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2002,10(3):180-187. 10.1053/joca.2001.0505
33. Gallelli L, Galasso O, Falcone D, Southworth S, Greco M, Ventura V, Romualdi P, Corigliano A, Terracciano R, Savino R, Gulletta E, Gasparini G, De Sarro G: The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2013, 21:1400-1408. 10.1016/j.joca.2013.06.026
34. Kasten P, Beverungen M, Lorenz H, Wieland J, Fehr M, Geiger F: Comparison of platelet-rich plasma and VEGF-transfected mesenchymal stem cells on vascularization and bone formation in a critical-size bone defect. Cells Tissues Organs 2012,196(6):523-533. 10.1159/000337490
35. Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K: VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 2011,17(7):347-362. 10.1016/j.molmed.2011.01.015
36. Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD: VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012,22(1):146-157. 10.1016/j.devcel.2011.11.002
37. Liu Y, Berendsen AD, Jia S, Lotinun S, Baron R, Ferrara N, Olsen BR: Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest 2012,122(9):3101-3113. 10.1172/JCI61209
38. Martinez P, Esbrit P, Rodrigo A, Alvarez-Arroyo MV, Martinez ME: Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Osteoporos Int 2002,13(11):874-881. 10.1007/s001980200120
39. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2474/15/437/prepub